Analyst Ratings For NASDAQ:CFRX – ContraFect (NASDAQ:CFRX)
Today, Chardan Capital initiated coverage on NASDAQ:CFRX – ContraFect (NASDAQ:CFRX) with a Buy with a price target of $2.80.
Some recent analyst ratings include
- 6/15/2018-Chardan Capital initiated coverage with a Buy rating.
- 5/25/2017-Maxim Group Reiterated Rating of Hold.
- 9/28/2016-William Blair initiated coverage with a Outperform rating.
Recent Insider Trading Activity For NASDAQ:CFRX – ContraFect (NASDAQ:CFRX)
NASDAQ:CFRX – ContraFect (NASDAQ:CFRX) has insider ownership of 9.30% and institutional ownership of 59.16%.
- On 7/25/2017 Cara M Cassino, Insider, bought 8,000 with an average share price of $1.24 per share and the total transaction amounting to $9,920.00.
- On 7/25/2017 Joshua B Muntner, SVP, bought 2,000 with an average share price of $1.24 per share and the total transaction amounting to $2,480.00.
- On 7/25/2017 Sol J Barer, Director, bought 40,000 with an average share price of $1.24 per share and the total transaction amounting to $49,600.00.
- On 7/25/2017 Steven C Gilman, CEO, bought 800 with an average share price of $1.24 per share and the total transaction amounting to $992.00.
- On 7/27/2016 Steven C Gilman, CEO, bought 20,000 with an average share price of $2.48 per share and the total transaction amounting to $49,600.00.
- On 11/17/2015 Daniel Couto, SVP, sold 2,872 with an average share price of $3.81 per share and the total transaction amounting to $10,942.32.
- On 11/3/2015 Daniel Couto, SVP, sold 2,867 with an average share price of $4.23 per share and the total transaction amounting to $12,127.41.
Recent Trading Activity for NASDAQ:CFRX – ContraFect (NASDAQ:CFRX)
Shares of NASDAQ:CFRX – ContraFect closed the previous trading session at 2.05 up +0.05 2.50% with 2.049999952316284 shares trading hands.